A study conducted in previous SARS patients found a more deeply decrease in CD3+, CD4+, and CD8+ T cell counts and the ratio CD4+/CD8+ in the early acute phase of SARS in contrast to other viruses such as HIV-1, CMV, or EBV infection, which may suggest a specific immune pathology response to coronavirus [6]. This evidence concerns the gene CD4 and severe acute respiratory syndrome.